glp-1-based therapy Oral Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Center for Nutritional Psychology |

Cornell S (2020) A review of GLP-1 receptor agonists in type 2 diabetes: a focus on the mechanism of action of once-weekly agents

CoronationBio has licensed the intellectual property of ODN derivatives for the treatment of obesity and cardio-metabolic diseases and is continuing to work with me and other authors of this manuscript to translate drug candidates into the clinic

Staying active helps preserve muscle, supports metabolism, improves balance and enhances overall well-being during weight changes

For example, stress, toxins in the environment, and inadequate nutrition can all lead to lower levels of this antioxidant

C., Dermody, S

Mattson et al., 2018), improves leaky gut problems and gut disorders (Rinninella et al., 2020), diminishes overweight and diabetes (Anton et al., 2018), stimulates the release of brain-derived neurotrophic factor (which stimulates the growth of nerves) (Mattson et al., 2018), and helps stave off neurodegenerative diseases like Alzheimers and Parkinsons (Mattson and Arumugam, 2018)